Asset Details
Do you wish to reserve the book?
Oxytocin increases physiological linkage during group therapy for methamphetamine use disorder: a randomized clinical trial
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Oxytocin increases physiological linkage during group therapy for methamphetamine use disorder: a randomized clinical trial
Do you wish to request the book?
Oxytocin increases physiological linkage during group therapy for methamphetamine use disorder: a randomized clinical trial
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Oxytocin increases physiological linkage during group therapy for methamphetamine use disorder: a randomized clinical trial
2021
Overview
Patients and psychotherapists often exhibit behavioral, psychological, and physiological similarity. Here, we test whether oxytocin—a neuropeptide that can enhance expressivity and social perception—influences time-lagged “linkage” of autonomic nervous system responses among participants and facilitators during group therapy. Physiological linkage estimates (
n
= 949) were created from ten cohorts, each with two facilitators (
n
= 5) and four to six participants (
n
= 48), over six weekly sessions of group therapy for methamphetamine use disorder. All participants of a cohort received oxytocin or placebo intranasally in a randomized double-blind procedure before each session. Cardiac interbeat intervals (IBI) were measured continuously during sessions to estimate physiological linkage, operationalized as one cohort-mate’s IBI reactivity during one minute predicting another cohort-mate’s IBI reactivity during the following minute. In oxytocin cohorts, participants and facilitators experienced significant physiological linkage to their cohort-mates (i.e., their physiological responses were predicted by the prior responses of their cohort-mates) and significantly more linkage than people in placebo cohorts. Both effects occurred during the first and second sessions but not later sessions. Results suggest that oxytocin may enhance psychosocial processes often associated with linkage—such as social engagement—in groups and highlight oxytocin’s potential to improve group cohesion during group therapy.
Clinical Trials Registration: NCT02881177, First published on 26/08/2016.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
/ 631/477
/ Adult
/ Aged
/ Amphetamine-Related Disorders - diagnosis
/ Amphetamine-Related Disorders - etiology
/ Amphetamine-Related Disorders - therapy
/ Central Nervous System Stimulants - adverse effects
/ Humanities and Social Sciences
/ Humans
/ Male
/ Methamphetamine - adverse effects
/ NCT
/ Oxytocin
/ Oxytocin - administration & dosage
/ Placebos
/ Psychotherapy, Group - methods
/ Science
Seems like something went wrong :( Kindly try again later!